CN1131025C - 用于制备含有大量药物的快速崩解和快速溶解的组合物的颗粒 - Google Patents

用于制备含有大量药物的快速崩解和快速溶解的组合物的颗粒 Download PDF

Info

Publication number
CN1131025C
CN1131025C CN97196057A CN97196057A CN1131025C CN 1131025 C CN1131025 C CN 1131025C CN 97196057 A CN97196057 A CN 97196057A CN 97196057 A CN97196057 A CN 97196057A CN 1131025 C CN1131025 C CN 1131025C
Authority
CN
China
Prior art keywords
granule
water
weight
tablet
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97196057A
Other languages
English (en)
Chinese (zh)
Other versions
CN1224348A (zh
Inventor
B·L·J·狄杰克格拉夫
A·穆兰布鲁赫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
YAMAMOUCHI EURPE BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8224133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1131025(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by YAMAMOUCHI EURPE BV filed Critical YAMAMOUCHI EURPE BV
Publication of CN1224348A publication Critical patent/CN1224348A/zh
Application granted granted Critical
Publication of CN1131025C publication Critical patent/CN1131025C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
CN97196057A 1996-07-03 1997-06-19 用于制备含有大量药物的快速崩解和快速溶解的组合物的颗粒 Expired - Lifetime CN1131025C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96201829 1996-07-03
EP96201829.7 1996-07-03
US08/770,421 1996-12-20
US08/770,421 US5837292A (en) 1996-07-03 1996-12-20 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Publications (2)

Publication Number Publication Date
CN1224348A CN1224348A (zh) 1999-07-28
CN1131025C true CN1131025C (zh) 2003-12-17

Family

ID=8224133

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97196057A Expired - Lifetime CN1131025C (zh) 1996-07-03 1997-06-19 用于制备含有大量药物的快速崩解和快速溶解的组合物的颗粒

Country Status (36)

Country Link
US (1) US5837292A (fr)
EP (1) EP0910344B1 (fr)
JP (1) JP4159607B2 (fr)
CN (1) CN1131025C (fr)
AR (1) AR008252A1 (fr)
AT (1) ATE237314T1 (fr)
AU (1) AU731276B2 (fr)
BG (1) BG64114B1 (fr)
BR (1) BR9710181B1 (fr)
CA (1) CA2258841C (fr)
CO (1) CO4890859A1 (fr)
CZ (1) CZ295893B6 (fr)
DE (1) DE69720995T2 (fr)
DK (1) DK0910344T3 (fr)
EA (1) EA001537B1 (fr)
EG (1) EG23814A (fr)
ES (1) ES2197351T3 (fr)
HK (1) HK1021511A1 (fr)
HU (1) HU225115B1 (fr)
ID (1) ID17128A (fr)
IL (1) IL127364A (fr)
JO (1) JO1969B1 (fr)
MY (1) MY116124A (fr)
NO (1) NO320767B1 (fr)
NZ (1) NZ333247A (fr)
PE (1) PE89798A1 (fr)
PL (1) PL188235B1 (fr)
PT (1) PT910344E (fr)
SI (1) SI0910344T1 (fr)
SK (1) SK284175B6 (fr)
TN (1) TNSN97114A1 (fr)
TR (1) TR199802762T2 (fr)
TW (1) TW473392B (fr)
UA (1) UA61917C2 (fr)
WO (1) WO1998001114A1 (fr)
ZA (1) ZA975848B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912373A (zh) * 2010-08-24 2010-12-15 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
JP4827296B2 (ja) * 1998-06-11 2011-11-30 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー デラビルジン錠製剤
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
WO2000069417A1 (fr) * 1999-05-14 2000-11-23 Eli Lilly And Company Elaboration d'un produit pharmaceutique en vrac uniformement dissout
HU227070B1 (en) * 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
CZ20032138A3 (cs) * 2001-02-05 2005-03-16 R. P. Scherer Technologies, Inc. Způsoby a prostředky pro zeslabení chuti farmaceuticky aktivních činidel
EP1285649A1 (fr) * 2001-08-23 2003-02-26 Cimex AG Comprimé dispersible à deux couches comprenant de l'amoxicilline et du clavulanate dans des couches séparées
RU2004123621A (ru) * 2002-02-01 2005-04-10 Пфайзер Продактс Инк. (Us) Лекарственные формы с немедленным высвобождением, содержащие твердые дисперсии лекарств
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
AU2003249116A1 (en) * 2002-07-16 2004-02-02 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
US20070014850A1 (en) * 2002-08-02 2007-01-18 Ramalingam Manikandan Process for the preparation of dispersible tablets of cephalexin
JP4702763B2 (ja) * 2003-07-30 2011-06-15 塩野義製薬株式会社 結晶セルロースを含有する安定な錠剤
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
EP2316442A1 (fr) * 2003-09-12 2011-05-04 Amgen Inc. Composition à base de composé actif aux récepteurs au calcium, à vitesse de dissolution rapide
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
EP1681050A1 (fr) * 2005-01-13 2006-07-19 Strides Arcolab Limited Composition pharmaceutique dispersible avec libération prolongée
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2043613A1 (fr) * 2006-07-14 2009-04-08 Fmc Corporation Forme solide
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2397161B1 (fr) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Composition de particule se désintégrant et matériau moulé par compression se désintégrant rapidement comprenant celle-ci
EP2575777A1 (fr) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique
WO2013151517A1 (fr) * 2012-04-04 2013-10-10 Mahmut Bilgic Formulations en comprimés comprenant du cefpodoxime proxétil et de l'acide clavulanique
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
KR102415876B1 (ko) * 2014-04-21 2022-06-30 주식회사 다이셀 미소섬유상 셀룰로오스를 포함하는 붕해성 입자 조성물
CN110051639B (zh) * 2019-03-15 2021-08-31 河北嘉迈医药科技有限公司 一种快速崩解型尼麦角林片及其制备方法
CN117683469A (zh) * 2023-10-24 2024-03-12 绍兴拓邦新能源股份有限公司 一种晶硅片背面碱抛光固态添加剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
EP0200252B1 (fr) * 1985-05-02 1999-03-10 Yamanouchi Europe B.V. Comprimés contenant de la triméthoprime et un sulfonamide
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
ES2060737T3 (es) * 1988-02-25 1994-12-01 Yamanouchi Europ Bv Procedimiento de preparacion de un granulado farmaceutico.
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
IL109097A0 (en) * 1993-04-03 1994-06-24 Knoll Ag Delayed release micro tablet of beta-phenylpropiophenone derivatives and its production

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912373A (zh) * 2010-08-24 2010-12-15 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法

Also Published As

Publication number Publication date
BG64114B1 (bg) 2004-01-30
MY116124A (en) 2003-11-28
JP2000513727A (ja) 2000-10-17
CO4890859A1 (es) 2000-02-28
SK284175B6 (sk) 2004-10-05
NZ333247A (en) 2000-07-28
DE69720995D1 (de) 2003-05-22
CZ295893B6 (cs) 2005-11-16
JO1969B1 (en) 1997-12-15
HUP9903308A2 (hu) 2000-03-28
TR199802762T2 (xx) 1999-03-22
PL330958A1 (en) 1999-06-21
US5837292A (en) 1998-11-17
HUP9903308A3 (en) 2001-03-28
EP0910344B1 (fr) 2003-04-16
BG103047A (en) 1999-07-30
ID17128A (id) 1997-12-04
ES2197351T3 (es) 2004-01-01
CA2258841C (fr) 2006-05-30
ATE237314T1 (de) 2003-05-15
AU731276B2 (en) 2001-03-29
NO320767B1 (no) 2006-01-23
HU225115B1 (hu) 2006-06-28
DE69720995T2 (de) 2003-11-13
TNSN97114A1 (fr) 2005-03-15
AU3342197A (en) 1998-02-02
ZA975848B (en) 1999-04-12
SK176798A3 (en) 2000-04-10
TW473392B (en) 2002-01-21
PE89798A1 (es) 1999-01-12
EP0910344A1 (fr) 1999-04-28
UA61917C2 (uk) 2003-12-15
HK1021511A1 (en) 2000-06-16
PL188235B1 (pl) 2004-12-31
JP4159607B2 (ja) 2008-10-01
NO986157D0 (no) 1998-12-28
CN1224348A (zh) 1999-07-28
BR9710181A (pt) 1999-08-10
AR008252A1 (es) 1999-12-29
EA001537B1 (ru) 2001-04-23
SI0910344T1 (en) 2003-08-31
DK0910344T3 (da) 2003-07-07
CZ699A3 (cs) 1999-04-14
BR9710181B1 (pt) 2009-08-11
EG23814A (en) 2007-09-12
IL127364A (en) 2003-04-10
NO986157L (no) 1999-02-01
WO1998001114A1 (fr) 1998-01-15
IL127364A0 (en) 1999-10-28
EA199900075A1 (ru) 1999-06-24
PT910344E (pt) 2003-09-30
CA2258841A1 (fr) 1998-01-15

Similar Documents

Publication Publication Date Title
CN1131025C (zh) 用于制备含有大量药物的快速崩解和快速溶解的组合物的颗粒
EP0223590B1 (fr) Compositions à libération retardée contenant des éthers hydroxypropyl cellulosiques
US8337897B2 (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
EP0330284B1 (fr) Procédé de préparation d'un granulé pharmaceutique
US20040197402A1 (en) Oxcarbazepine dosage forms
JP2008528456A (ja) 親油性結晶性物質としてカンデサルタンシレキセチルを含む新規な医薬組成物
EP0159852A2 (fr) Compositions pharmaceutiques à compression directe
CN1882321B (zh) 包含盐酸文拉法辛的小丸
JPH08310969A (ja) 固形薬品組成物及びその製造方法
JPH08198761A (ja) ポリカルボフィルカルシウム含有製剤
MXPA06010805A (es) Formulacion de claritromicina de libracion prolongada.
WO2021091188A1 (fr) Composition pharmaceutique à libération prolongée pour une administration orale, contenant du rebamipide ou un sel pharmaceutiquement acceptable de celui-ci
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
KR100475260B1 (ko) 높은양의약을함유하는,신속-붕해되고신속-용해되는조성물제조용과립
KR20180035723A (ko) 라코사미드 서방성 제제
JP2602515B2 (ja) 球形顆粒剤
KR910004481B1 (ko) 용출성이 개량된 제제 조성물
AU2002302888A1 (en) Oxcarbazepine dosage forms
TW201249802A (en) Tolvaptan solid dispersion and its preparation method
CA2052637A1 (fr) Preparation pharmaceutique presentant de meilleures proprietes d'absorption

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ANSTEIN PHARMACY EUROPE CO., LTD.

Free format text: FORMER NAME OR ADDRESS: YAMAMOUCHI EURPE B. V.

CP03 Change of name, title or address

Address after: Holland Leiderdorp

Patentee after: Yamanouchi Europ BV

Address before: Holland Leiderdorp

Patentee before: Yamamouchi Eurpe B. V.

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1056297

Country of ref document: HK

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: No. 62 Wells Road, Holland, Leiden

Patentee after: Yamanouchi Europ BV

Address before: Holland Leiderdorp

Patentee before: Yamanouchi Europ BV

CX01 Expiry of patent term

Granted publication date: 20031217

CX01 Expiry of patent term